Company intelligence / Profile preview

Allied Minds

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Allied Minds forms and funds early-stage life science and health technology companies from university and federal lab IP; its Allied-Bristol Life Sciences (ABLS) partnership with Bristol Myers Squibb advances innovative assets from academic labs to pre-clinical and lead optimization stages, with some subsidiaries focused on fibrosis, oncology, and novel biological targets[6].

Therapeutic areas: OncologyCardiovascularImmunologyRare Diseases
Modalities: Small moleculeBiologicMedical device
Industry: Investors

Partnerships

Bristol Myers SquibbGeneral Electric VenturesMITREUS Department of DefenseUS government labsMultiple US universities

Beyond the preview

Go deeper on Allied Minds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Allied Minds.

Explore the full profile